A prospective, randomized, double-blind, placebo-controlled trial to compare the safety, tolerability, immunogenicity and efficacy of one dose and two doses of a liquid formulation of influenza virus vaccine, trivalent, types A & B, live cold-adapted (CAIV-T) compared with placebo in healthy children
Phase of Trial: Phase III
Latest Information Update: 01 May 2009
At a glance
- Drugs Influenza virus vaccine live (Primary)
- Indications Influenza virus infections
- Focus Therapeutic Use
- 31 Oct 2005 New trial record.